Details of the Drug | DrugMAP

General Information of Drug (ID: DMZ12V4)

Drug Name	PMID26882240-Compound-15
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight (mw)			396.5
	Logarithm of the Partition Coefficient (xlogp)			4.1
	Rotatable Bond Count (rotbonds)			3
	Hydrogen Bond Donor Count (hbonddonor)			0
	Hydrogen Bond Acceptor Count (hbondacc)			6
Chemical Identifiers	Formula C20H16N2O3S2 IUPAC Name 5-[4-(4-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-6-yl]thiophene-2-carbonitrile Canonical SMILES CC1=CC=C(C=C1)S(=O)(=O)N2CCOC3=C2C=C(C=C3)C4=CC=C(S4)C#N InChI InChI=1S/C20H16N2O3S2/c1-14-2-6-17(7-3-14)27(23,24)22-10-11-25-19-8-4-15(12-18(19)22)20-9-5-16(13-21)26-20/h2-9,12H,10-11H2,1H3 InChIKey VIWNRKLYEZMKCY-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 52934476 TTD ID D08VON

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hypoxia-inducible factor 1 (HIF-1)	TTUX68I	NOUNIPROTAC	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015).Expert Opin Ther Pat. 2016;26(3):309-22.